Forskning ved Københavns Universitet - Københavns Universitet

Forside

A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours. / Lassen, U; Molife, L R; Sorensen, Janice Marie; Engelholm, S-A; Vidal, L; Sinha, R; Penson, R T; Buhl-Jensen, P; Crowley, E; Tjornelund, J; Knoblauch, P; de Bono, J S; Buhl-Jensen, P.

I: B J C, Bind 103, Nr. 1, 29.06.2010, s. 12-7.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Lassen, U, Molife, LR, Sorensen, JM, Engelholm, S-A, Vidal, L, Sinha, R, Penson, RT, Buhl-Jensen, P, Crowley, E, Tjornelund, J, Knoblauch, P, de Bono, JS & Buhl-Jensen, P 2010, 'A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours', B J C, bind 103, nr. 1, s. 12-7. https://doi.org/10.1038/sj.bjc.6605726

APA

Lassen, U., Molife, L. R., Sorensen, J. M., Engelholm, S-A., Vidal, L., Sinha, R., ... Buhl-Jensen, P. (2010). A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours. B J C, 103(1), 12-7. https://doi.org/10.1038/sj.bjc.6605726

Vancouver

Lassen U, Molife LR, Sorensen JM, Engelholm S-A, Vidal L, Sinha R o.a. A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours. B J C. 2010 jun 29;103(1):12-7. https://doi.org/10.1038/sj.bjc.6605726

Author

Lassen, U ; Molife, L R ; Sorensen, Janice Marie ; Engelholm, S-A ; Vidal, L ; Sinha, R ; Penson, R T ; Buhl-Jensen, P ; Crowley, E ; Tjornelund, J ; Knoblauch, P ; de Bono, J S ; Buhl-Jensen, P. / A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours. I: B J C. 2010 ; Bind 103, Nr. 1. s. 12-7.

Bibtex

@article{4bb0530fd85d48aa871f136ded87f422,
title = "A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours",
abstract = "This phase I study assessed the maximum tolerated dose, dose-limiting toxicity (DLT) and pharmacokinetics of belinostat with carboplatin and paclitaxel and the anti-tumour activity of the combination in solid tumours.",
author = "U Lassen and Molife, {L R} and Sorensen, {Janice Marie} and S-A Engelholm and L Vidal and R Sinha and Penson, {R T} and P Buhl-Jensen and E Crowley and J Tjornelund and P Knoblauch and {de Bono}, {J S} and P Buhl-Jensen",
year = "2010",
month = "6",
day = "29",
doi = "http://dx.doi.org/10.1038/sj.bjc.6605726",
language = "English",
volume = "103",
pages = "12--7",
journal = "B J C",
issn = "0007-0920",
publisher = "nature publishing group",
number = "1",

}

RIS

TY - JOUR

T1 - A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours

AU - Lassen, U

AU - Molife, L R

AU - Sorensen, Janice Marie

AU - Engelholm, S-A

AU - Vidal, L

AU - Sinha, R

AU - Penson, R T

AU - Buhl-Jensen, P

AU - Crowley, E

AU - Tjornelund, J

AU - Knoblauch, P

AU - de Bono, J S

AU - Buhl-Jensen, P

PY - 2010/6/29

Y1 - 2010/6/29

N2 - This phase I study assessed the maximum tolerated dose, dose-limiting toxicity (DLT) and pharmacokinetics of belinostat with carboplatin and paclitaxel and the anti-tumour activity of the combination in solid tumours.

AB - This phase I study assessed the maximum tolerated dose, dose-limiting toxicity (DLT) and pharmacokinetics of belinostat with carboplatin and paclitaxel and the anti-tumour activity of the combination in solid tumours.

U2 - http://dx.doi.org/10.1038/sj.bjc.6605726

DO - http://dx.doi.org/10.1038/sj.bjc.6605726

M3 - Journal article

VL - 103

SP - 12

EP - 17

JO - B J C

JF - B J C

SN - 0007-0920

IS - 1

ER -

ID: 34079775